Pancreatic Cancer–Stellate–Endothelial Spheroid Drug and Conditioned-Medium Assays
Compare four defined triple-cell pancreatic spheroids for chemotherapy response and separate conditioned-medium effects on endothelial organization.
Tumor ModelsSpheroids
Groenenborger campus entrance at the University of Antwerp, photographed in June 2022. (OliCol11, CC BY-SA 4.0)
Research Applications
Test how cancer/stellate background and tissue structure influence aggregate drug response and secreted angiogenic activity.
Model & Design
Human BxPC-3 or MiaPaCa-2 cancer lines, RLT-PSC or hPSC21 stellate lines and HMEC-1 dermal endothelium in defined cell-line cocultures.
Experimental Format
Three-day formation in MCDB131 with 0.24% methylcellulose. Cancer:stellate:endothelial seeding ratios are BxPC-3/RLT-PSC 7:2:4 (5,000 cells), BxPC-3/hPSC21 6:5:3 (7,000), MiaPaCa-2/RLT-PSC 6:3:3 (3,500) and MiaPaCa-2/hPSC21 5:6:4 (4,500). Five-day gemcitabine (2.5 nM–10 μM)/paclitaxel monotherapy and combination assays. The source gives inconsistent paclitaxel:gemcitabine fixed ratios: 1:5 in Methods and 1:8 in Figure 3.
Model Components
Component
Viability
Description
CellTiter-Glo ATP normalized to untreated and 5 μM staurosporine controls. Response-curve area is used where IC50 cannot be estimated.
Component
Endothelial assay
Description
Untreated spheroid-conditioned medium and VEGF ELISA; a separate six-hour HMEC-1/Cultrex tube assay uses IKOSA image-analysis software for loops, length, area and branch points.
Measurements & Endpoints
Five-day aggregate ATP response-curve area
Three-day composition/diameter
Conditioned-medium VEGF
Six-hour endothelial organization
Analysis
Compare each cancer background with its own monoculture and keep starting cell counts, final fractions and replication units distinct. A conditioned-medium tube assay is separate from vascularization inside the spheroid.
Published Evidence
Study Sample
Four defined cocultures. Drug-response measurements n ≥ 7 from three independent experiments; VEGF n = 3 from one experiment; tube assay n ≥ 8 from three experiments.
Comparison
BxPC-3 and MiaPaCa-2 monocultures, alternative cancer/stellate pairings, untreated/full-death drug controls and positive/negative tube-assay media.
Finding
BxPC-3 monocultures were more resistant than their cocultures; MiaPaCa-2 overall sensitivity did not significantly change. BxPC-3/RLT-PSC provided a relatively resistant triple-culture comparison. Conditioned media produced distinct tube area, length and branching patterns without many closed loops.
Interpretation & Limits
The source fixed combination ratio differs between Methods and Figure 3.
Different starting cell counts and aggregate ATP prevent cell-type-specific survival inference.
HMEC-1 is dermal endothelium; no perfused pancreatic vessel network.
No patient-derived or matched clinical treatment validation; the conditioned-media comparison did not test antiangiogenic therapy.
Study Design
Primary study comparisons of the named models, exposures and measured outcomes.
Four pancreatic cancer–stellate–endothelial spheroid combinations differed in structure, chemotherapy response and conditioned-medium effects on endothelial cells. Adding stromal cells reduced resistance in BxPC-3 cultures but did not significantly change the overall response of MiaPaCa-2 models.